Similar articles

• Na, K-activated ATPase activity during and after arrhythmic response to AY-22-241 in the canine heart.

  Dutta S, Zavecz JH, Marks BH, Rhee HM, Brar S, Richards SR, Bhat HB. Dutta S, et al. Ann N Y Acad Sci. 1974;242(0):671-82. doi: 10.1111/j.1749-6632.1974.tb19125.x. Ann N Y Acad Sci. 1974. PMID: 4279614 No abstract available.
• Cardiac glycoside sensitivity of (Na + +K + )-activated ATPase in new-born rats.

  Akera T, Hook JB, Tobin T, Brody TM. Akera T, et al. Res Commun Chem Pathol Pharmacol. 1972 Nov;4(3):699-706. Res Commun Chem Pathol Pharmacol. 1972. PMID: 4264311 No abstract available.
• The subcellular basis for the mechanism of inotropic action of cardiac glycosides.

  Lee KS, Klaus W. Lee KS, et al. Pharmacol Rev. 1971 Sep;23(3):193-261. Pharmacol Rev. 1971. PMID: 4255625 Review. No abstract available.
• The role of potassium in the inhibition by cardiac glycosides of (Na+-K+)-ATPase prepared from human heart [(proceedings)].

  De Pover A, Godfraind T. De Pover A, et al. Br J Pharmacol. 1976 Nov;58(3):413P-414P. Br J Pharmacol. 1976. PMID: 136282 Free PMC article. No abstract available.
• [Certain problems of pharmacodynamics, pharmacokinetics and the use of cardiac glycosides].

  Kukes VG, Volkov RIu. Kukes VG, et al. Kardiologiia. 1977 Sep;17(9):135-42. Kardiologiia. 1977. PMID: 144820 Review. Russian. No abstract available.